Development and Assessment of Nomogram Based on AFP Response for Patients with Unresectable Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors.
Yi ZhangHui ShenRuiying ZhengYueting SunXiaoyan XieMing-De LuBaoxian LiuGuang-Liang HuangPublished in: Cancers (2023)
The nomogram could predict PFS in patients with unresectable HCC receiving ICIs treatment and further help decision making in daily clinical practice.